Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways
ContributorsCarbone, Federico; Vuilleumier, Nicolas; Bertolotto, Maria; Burger, Fabienne; Galan, Katia; Roversi, Gloria; Tamborino, Carmine; Casetta, Ilaria; Seraceni, Silva; Trentini, Alessandro; Dallegri, Franco; Da Silva, Analina Raquel; Pende, Aldo; Artom, Nathan; Mach, François; Coen, Matteo ; Fainardi, Enrico; Montecucco, Fabrizio
Published inVascular pharmacology, vol. 64, no. 41, p. 16-27
Publication date2015
Abstract
Keywords
- Amino Acid Sequence
- Apolipoprotein A-I/chemistry/immunology
- Atherosclerosis/immunology
- Autoantibodies/biosynthesis/blood
- Biological Markers/analysis
- Chromatography, Affinity
- Enzyme-Linked Immunosorbent Assay
- Epitopes/chemistry/immunology
- Gene Expression
- Humans
- Immunoglobulin G/biosynthesis/blood
- Molecular Sequence Data
- Myocardial Infarction/blood/diagnosis/immunology/pathology
- Peptides/chemistry/immunology
- Plaque, Atherosclerotic/blood/diagnosis/immunology/pathology
- Sequence Analysis, Protein
Research group
Citation (ISO format)
CARBONE, Federico et al. Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. In: Vascular pharmacology, 2015, vol. 64, n° 41, p. 16–27. doi: 10.1016/j.vph.2014.11.007
Main files (1)
Article (Published version)
Identifiers
- PID : unige:46793
- DOI : 10.1016/j.vph.2014.11.007
- PMID : 25530154
ISSN of the journal1537-1891